SENS
Senseonics Holdings, Inc. Common StockstockNASDAQ
senseonics, inc. is a medical device startup company in germantown, maryland, usa (near washington, dc) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. utilizing breakthrough fluorescence sensing technology, the senseonics continuous glucose monitoring ("cgm") system is being designed to be the first fully implantable cgm that is highly accurate and stable throughout its long sensor life. the system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 8.59 | 2026-11-06 | +23.40% | 4.910 |
| 1M | 8.92 | 2026-10-13 | +18.83% | 3.516 |
| 3M | 7.73 | 2026-08-13 | +37.13% | 2.885 |
| 6M | 5.50 | 2026-05-13 | +92.73% | 2.462 |
| 1Y | 6.18 | 2025-11-13 | +71.52% | 2.358 |
| 2Y | 5.98 | 2024-11-13 | +77.14% | — |
| 5Y | 72.60 | 2021-11-12 | -85.40% | 1.883 |
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) stock price today is $10.60, and today's volume is 1,120,691. SENS is up 5.578% today. The 30 day average volume is 817,299. SENS market cap is $580.67M with 54.78M shares outstanding.